RRP9 and DDX21 as new biomarkers of colorectal cancer.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
27 Oct 2023
Historique:
medline: 2 11 2023
pubmed: 31 10 2023
entrez: 31 10 2023
Statut: ppublish

Résumé

Colorectal cancer originates from the epithelium of the large intestine and is a common malignant tumor in the gastrointestinal tract. However, the relationship between RRP9 and DDX21 and colorectal cancer (CRC) remains unclear. GSE134834, GSE206800, and GSE209892 profiles for CRC were downloaded from the gene expression omnibus database generated using GPL20115 and GPL23126. Differentially expressed genes (DEGs) were screened and weighted gene co-expression network analysis was performed. The construction and analysis of protein-protein interaction network. Functional enrichment analysis and gene set enrichment analysis were performed. Gene expression heat map was drawn and immune infiltration analysis was performed. Comparative toxicogenomics database analysis were performed to find the disease most related to the core gene. TargetScan was used to screen miRNAs regulating central DEGs. One thousand three hundred eighty DEGs were identified. According to gene ontology analysis, they were mainly concentrated in signal receptor activity regulation and metal titanase activity. Kyoto encyclopedia of gene and genome analysis showed that they mainly focused on IL17 signal pathway, PPAR signal pathway, protein digestion, and absorption, and the interaction of viral proteins with cytokines and cytokine receptors. The intersection of enrichment items and GOKEGG enrichment items of differentially expressed genes is mainly concentrated in PPAR signal pathway and the interaction of viral proteins with cytokines and cytokine receptors. The protein-protein interaction network obtained 16 core genes (MAD2L1, MELK, TPX2, UBE2C, RFC4, PLK1, RACGAP1, DKC1, DDX21, L Y AR, WDR3, RRP9, WDR43, NOLC1, BRIX1, and GTPBP4). Heat map of gene expression showed that core genes (TPX2, UBE2C, RFC4, PLK1, DKC1, LYAR, WDR3, NOLC1, and BRIX1) were not significantly differentially expressed between CRC and normal tissue samples. Core genes (MAD2L1, MELK, RACGAP1, RRP9, WDR43, DDX21, and GTPBP4) were highly expressed in CRC tissue samples and lowly expressed in normal tissue samples. Comparative toxicogenomics database analysis showed that 7 genes (MAD2L1, MELK, RACGAP1, RRP9, WDR43, DDX21, and GTPBP4) were related to necrosis, inflammation, tumor, precancerous symptoms, hemorrhage, and weightlessness. RRP9 and DDX21 are highly expressed in CRC. The higher the expression level of RRP9 and DDX21, the worse the prognosis.

Identifiants

pubmed: 37904456
doi: 10.1097/MD.0000000000034384
pii: 00005792-202310270-00112
pmc: PMC10615516
doi:

Substances chimiques

Peroxisome Proliferator-Activated Receptors 0
Cell Cycle Proteins 0
Biomarkers, Tumor 0
Cytokines 0
Receptors, Cytokine 0
Viral Proteins 0
DKC1 protein, human 0
Nuclear Proteins 0
GTPBP4 protein, human EC 3.6.1.-
MELK protein, human EC 2.7.1.-
DDX21 protein, human EC 3.6.1.-
LYAR protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e34384

Informations de copyright

Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Medicine (Baltimore). 2017 Oct;96(40):e8242
pubmed: 28984783
EMBO J. 1995 Sep 1;14(17):4350-6
pubmed: 7556076
Nat Commun. 2014 May 13;5:3733
pubmed: 24821572
Clin Lab Med. 2018 Jun;38(2):311-342
pubmed: 29776633
Int J Mol Sci. 2017 Jan 19;18(1):
pubmed: 28106826
Cytotechnology. 2021 Feb;73(1):1-11
pubmed: 33505109
Cancer. 2021 Jun 1;127(11):1880-1893
pubmed: 33784413
J Egypt Natl Canc Inst. 2020 Jul 17;32(1):30
pubmed: 32676803
EBioMedicine. 2019 Oct;48:648-655
pubmed: 31631043
Cell Death Dis. 2019 Mar 25;10(4):281
pubmed: 30911007
Ann Oncol. 2018 Jan 1;29(1):44-70
pubmed: 29155929
Nat Struct Mol Biol. 2015 Jan;22(1):11-9
pubmed: 25565028
Oxid Med Cell Longev. 2020 Oct 9;2020:3580719
pubmed: 33101586
Biochem Biophys Res Commun. 2018 Nov 10;505(4):1189-1194
pubmed: 30322617
Nat Protoc. 2019 Feb;14(2):482-517
pubmed: 30664679
Sci Rep. 2022 Dec 3;12(1):20902
pubmed: 36463288
Sci Rep. 2020 Dec 16;10(1):22085
pubmed: 33328538
Clin Cancer Res. 2011 Feb 15;17(4):700-9
pubmed: 21304002
Cancer Lett. 2021 Dec 1;522:255-268
pubmed: 34563640
Chin Med J (Engl). 2021 Mar 17;134(7):783-791
pubmed: 33734139
iScience. 2020 Nov 18;23(12):101811
pubmed: 33313488
Arch Argent Pediatr. 2021 Oct;119(5):e487-e498
pubmed: 34569749
Int J Mol Sci. 2021 May 23;22(11):
pubmed: 34071057
Adv Exp Med Biol. 2020;1217:297-315
pubmed: 31898235
Surg Pathol Clin. 2021 Sep;14(3):429-441
pubmed: 34373094
Front Oncol. 2019 Jul 09;9:587
pubmed: 31338327
Front Oncol. 2022 Nov 24;12:947054
pubmed: 36505822
Sci Rep. 2021 Dec 14;11(1):23938
pubmed: 34907282
Br J Surg. 1990 May;77(5):502-5
pubmed: 2354331
J Biol Chem. 2021 Nov;297(5):101307
pubmed: 34662580
Cell Commun Signal. 2022 Nov 24;20(1):188
pubmed: 36434608

Auteurs

Xiaoqian Chi (X)

Department of General Surgery, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.

Ning Yang (N)

Department of General Surgery, The First Affiliated Hospital, Hebei Medical University, Shijiazhuang, China.

Yabin Liu (Y)

Department of General Surgery, The Fourth Affiliated Hospital, Hebei Medical University, Shijiazhuang, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH